Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New therapeutic options for hepatitis C.

Laura Waters¹, Mark Nelson

¹Department of GU & HIV Medicine, Chelsea & Westminster Hospital, London, UK.

Current Opinion in Infectious Diseases

|November 1, 2006

Summary

New hepatitis C virus (HCV) therapies show promise, with agents demonstrating potent antiviral activity and improved treatment outcomes. Ongoing research and understanding of HCV will lead to novel targets and optimized treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Switching to doravirine-based antiretroviral therapy without genotypic resistance tests in virologically suppressed people with HIV.

AIDS (London, England)·2026

Same author

Missed opportunities to prevent HIV acquisition with pre-exposure prophylaxis: A mixed methods study of people with recently acquired HIV in the United Kingdom.

HIV medicine·2026

Same author

Risk of hypertension in people with HIV in the USA initiating modern antiretroviral regimens: pooled analysis of blood pressure data from five clinical trials.

The Journal of antimicrobial chemotherapy·2026

Same author

'Visual Literacy: Seeing the Skin' course effect on clinician observational and descriptive skills in skin of colour and white skin.

Clinical and experimental dermatology·2026

Same author

Associations between plasma biomarkers and changes in cognitive function over two years in people with and without HIV.

AIDS (London, England)·2025

Same author

Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Area of Science:

Hepatology
Virology
Pharmacology

Background:

Urgent need for novel anti-hepatitis C virus (HCV) therapies.
Advancements in in-vitro drug study technologies accelerate development.
Previous limitations in cell-culture and animal models for HCV research.

Purpose of the Study:

Review mechanisms of new and existing anti-HCV drugs.
Evaluate data for promising new agents and strategies.
Discuss progress in managing adverse events and optimizing treatment.

Main Methods:

Review of preclinical and clinical data for anti-HCV agents.
Analysis of drug mechanisms of action.
Examination of treatment response rates and adverse event management.

Related Experiment Videos

Main Results:

Several agents exhibit potent antiviral activity and synergism with existing therapies.
Improved treatment response rates achieved through better management of adverse events and tailored dosing.
Promising new agents and strategies are emerging from preclinical and clinical development.

Conclusions:

New anti-HCV agents show significant promise, despite early development stages.
Increased understanding of HCV biology will drive the discovery of new therapeutic targets.
Lessons from HIV treatment can inform the judicious use of new agents to prevent resistance.